The trial also recorded fewer cases of lung cancer in those on the treatment, consistent with basic research findings hinting that the same inflammatory pathway may initiate or spur tumor growth. (science.sciencemag.org)
Cell recycling (shown in green) is elevated in lung cancer cells treated with an established cancer drug. (salk.edu)